Rank | Gene Set | Z-score |
---|---|---|
1 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 6.47683305 |
2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.22905009 |
3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.03887422 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 5.78736781 |
5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.78736781 |
6 | neuron cell-cell adhesion (GO:0007158) | 5.48307454 |
7 | vocalization behavior (GO:0071625) | 5.06916211 |
8 | respiratory electron transport chain (GO:0022904) | 5.00422101 |
9 | gamma-aminobutyric acid transport (GO:0015812) | 4.95601880 |
10 | behavioral response to nicotine (GO:0035095) | 4.94121042 |
11 | electron transport chain (GO:0022900) | 4.90255323 |
12 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.84800682 |
13 | inner mitochondrial membrane organization (GO:0007007) | 4.81214329 |
14 | response to histamine (GO:0034776) | 4.66044956 |
15 | protein localization to synapse (GO:0035418) | 4.46545555 |
16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.37900273 |
17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.34346617 |
18 | neuron recognition (GO:0008038) | 4.33112220 |
19 | transmission of nerve impulse (GO:0019226) | 4.25120488 |
20 | dopamine transport (GO:0015872) | 4.18043668 |
21 | positive regulation of synapse assembly (GO:0051965) | 4.12350922 |
22 | mating behavior (GO:0007617) | 4.10615158 |
23 | synaptic vesicle exocytosis (GO:0016079) | 4.10492212 |
24 | L-fucose catabolic process (GO:0042355) | 4.04640936 |
25 | fucose catabolic process (GO:0019317) | 4.04640936 |
26 | L-fucose metabolic process (GO:0042354) | 4.04640936 |
27 | response to pheromone (GO:0019236) | 4.02722634 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94526541 |
29 | neurotransmitter catabolic process (GO:0042135) | 3.93476699 |
30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.91523626 |
31 | synaptic vesicle maturation (GO:0016188) | 3.84738609 |
32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83999485 |
33 | presynaptic membrane assembly (GO:0097105) | 3.82528723 |
34 | regulation of glutamate secretion (GO:0014048) | 3.76088319 |
35 | glutamate receptor signaling pathway (GO:0007215) | 3.75821108 |
36 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.72231466 |
37 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.72231466 |
38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.71446484 |
39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.70695313 |
40 | chaperone-mediated protein transport (GO:0072321) | 3.59951246 |
41 | startle response (GO:0001964) | 3.52551554 |
42 | presynaptic membrane organization (GO:0097090) | 3.52323198 |
43 | suckling behavior (GO:0001967) | 3.51709735 |
44 | protein localization to cilium (GO:0061512) | 3.46306834 |
45 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.45435567 |
46 | detection of calcium ion (GO:0005513) | 3.44862682 |
47 | cAMP catabolic process (GO:0006198) | 3.44285883 |
48 | dopamine biosynthetic process (GO:0042416) | 3.43038782 |
49 | hydrogen ion transmembrane transport (GO:1902600) | 3.41547563 |
50 | synaptic transmission, dopaminergic (GO:0001963) | 3.41546521 |
51 | neuron remodeling (GO:0016322) | 3.41228324 |
52 | catecholamine transport (GO:0051937) | 3.40924770 |
53 | neuron-neuron synaptic transmission (GO:0007270) | 3.40890250 |
54 | serotonin metabolic process (GO:0042428) | 3.39258636 |
55 | neurotransmitter secretion (GO:0007269) | 3.38229564 |
56 | neuronal action potential propagation (GO:0019227) | 3.32797323 |
57 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.31687112 |
58 | primary amino compound metabolic process (GO:1901160) | 3.31322769 |
59 | opioid receptor signaling pathway (GO:0038003) | 3.30120293 |
60 | axonal fasciculation (GO:0007413) | 3.29168732 |
61 | C4-dicarboxylate transport (GO:0015740) | 3.26070290 |
62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24980006 |
63 | neurotransmitter transport (GO:0006836) | 3.21968784 |
64 | postsynaptic membrane organization (GO:0001941) | 3.20368159 |
65 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.19089733 |
66 | regulation of action potential (GO:0098900) | 3.18256634 |
67 | regulation of vesicle fusion (GO:0031338) | 3.17144595 |
68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13170002 |
69 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12822320 |
70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.12578174 |
71 | righting reflex (GO:0060013) | 3.12491281 |
72 | locomotory exploration behavior (GO:0035641) | 3.10664579 |
73 | cyclic nucleotide catabolic process (GO:0009214) | 3.10473710 |
74 | dendritic spine morphogenesis (GO:0060997) | 3.10402903 |
75 | glutamate secretion (GO:0014047) | 3.10399288 |
76 | oxygen transport (GO:0015671) | 3.08623004 |
77 | regulation of neurotransmitter levels (GO:0001505) | 3.08077805 |
78 | neuronal action potential (GO:0019228) | 3.07884354 |
79 | synapse assembly (GO:0007416) | 3.07422482 |
80 | ATP biosynthetic process (GO:0006754) | 3.06260075 |
81 | protein K11-linked deubiquitination (GO:0035871) | 3.05633995 |
82 | proton transport (GO:0015992) | 3.05509206 |
83 | membrane depolarization during action potential (GO:0086010) | 3.05462705 |
84 | neuromuscular synaptic transmission (GO:0007274) | 3.04862420 |
85 | layer formation in cerebral cortex (GO:0021819) | 3.04313875 |
86 | regulation of synapse assembly (GO:0051963) | 3.03837294 |
87 | transferrin transport (GO:0033572) | 3.03629691 |
88 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.03587066 |
89 | female mating behavior (GO:0060180) | 3.03072725 |
90 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.02544628 |
91 | indolalkylamine metabolic process (GO:0006586) | 3.02046077 |
92 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02033825 |
93 | hydrogen transport (GO:0006818) | 3.01486843 |
94 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.98703974 |
95 | kynurenine metabolic process (GO:0070189) | 2.98530803 |
96 | negative regulation of amino acid transport (GO:0051956) | 2.98341933 |
97 | indole-containing compound metabolic process (GO:0042430) | 2.97661536 |
98 | neurotransmitter biosynthetic process (GO:0042136) | 2.96707664 |
99 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.96344670 |
100 | synaptic transmission, glutamatergic (GO:0035249) | 2.93910285 |
101 | DNA deamination (GO:0045006) | 2.93852829 |
102 | striatum development (GO:0021756) | 2.92980375 |
103 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.92071825 |
104 | proline transport (GO:0015824) | 2.90914417 |
105 | behavioral response to cocaine (GO:0048148) | 2.89589802 |
106 | exploration behavior (GO:0035640) | 2.89549794 |
107 | GTP biosynthetic process (GO:0006183) | 2.89540563 |
108 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.89370116 |
109 | cellular ketone body metabolic process (GO:0046950) | 2.89073865 |
110 | fear response (GO:0042596) | 2.87893725 |
111 | reflex (GO:0060004) | 2.86791748 |
112 | regulation of dopamine metabolic process (GO:0042053) | 2.85605290 |
113 | regulation of catecholamine metabolic process (GO:0042069) | 2.85605290 |
114 | long-term memory (GO:0007616) | 2.83754191 |
115 | trivalent inorganic cation transport (GO:0072512) | 2.83687795 |
116 | ferric iron transport (GO:0015682) | 2.83687795 |
117 | social behavior (GO:0035176) | 2.83306035 |
118 | intraspecies interaction between organisms (GO:0051703) | 2.83306035 |
119 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82925177 |
120 | retinal cone cell development (GO:0046549) | 2.82441603 |
121 | indole-containing compound catabolic process (GO:0042436) | 2.82137808 |
122 | indolalkylamine catabolic process (GO:0046218) | 2.82137808 |
123 | tryptophan catabolic process (GO:0006569) | 2.82137808 |
124 | behavioral defense response (GO:0002209) | 2.81769524 |
125 | behavioral fear response (GO:0001662) | 2.81769524 |
126 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.80961249 |
127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.80961249 |
128 | membrane hyperpolarization (GO:0060081) | 2.79640052 |
129 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77599443 |
130 | positive regulation of action potential (GO:0045760) | 2.76120546 |
131 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.76057922 |
132 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75892608 |
133 | alanine transport (GO:0032328) | 2.74411224 |
134 | protein neddylation (GO:0045116) | 2.72255680 |
135 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.70828256 |
136 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.70741344 |
137 | multi-organism reproductive behavior (GO:0044705) | 2.69533780 |
138 | membrane depolarization (GO:0051899) | 2.68863802 |
139 | protein-cofactor linkage (GO:0018065) | 2.68290319 |
140 | tryptophan metabolic process (GO:0006568) | 2.65912004 |
141 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.64903597 |
142 | nucleobase catabolic process (GO:0046113) | 2.61525282 |
143 | regulation of neurotransmitter uptake (GO:0051580) | 2.59265979 |
144 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.54665277 |
145 | behavioral response to ethanol (GO:0048149) | 2.54207543 |
146 | action potential (GO:0001508) | 2.52151621 |
147 | * synaptic transmission (GO:0007268) | 2.51452257 |
148 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.51288151 |
149 | ketone body metabolic process (GO:1902224) | 2.51059808 |
150 | regulation of cilium movement (GO:0003352) | 2.50530106 |
151 | sulfation (GO:0051923) | 2.50086002 |
152 | protein polyglutamylation (GO:0018095) | 2.48116038 |
153 | negative regulation of telomere maintenance (GO:0032205) | 2.47788403 |
154 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.45362489 |
155 | regulation of synapse structural plasticity (GO:0051823) | 2.41599026 |
156 | cellular potassium ion transport (GO:0071804) | 2.41248999 |
157 | potassium ion transmembrane transport (GO:0071805) | 2.41248999 |
158 | auditory behavior (GO:0031223) | 2.40705063 |
159 | regulation of synaptic vesicle transport (GO:1902803) | 2.38591254 |
160 | glycosphingolipid biosynthetic process (GO:0006688) | 2.37811164 |
161 | neural tube formation (GO:0001841) | 2.37503117 |
162 | regulation of neurotransmitter transport (GO:0051588) | 2.36429491 |
163 | activated T cell proliferation (GO:0050798) | 2.36372579 |
164 | atrial cardiac muscle cell action potential (GO:0086014) | 2.34945060 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.34205700 |
2 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.54338513 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38209767 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00516049 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99472902 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89527480 |
7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64137578 |
8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.55137642 |
9 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.45834586 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45708752 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45675686 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43439751 |
13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42055480 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42055480 |
15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37467211 |
16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36456579 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35660009 |
18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32305744 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31354801 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27660000 |
21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.26313554 |
22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.20952584 |
23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15540712 |
24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14010670 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07515132 |
26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01450920 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94122998 |
28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92307793 |
29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.85810532 |
30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85723812 |
31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.83166399 |
32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81412013 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79559712 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78818447 |
35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78510236 |
36 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.78129258 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77908999 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77573049 |
39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75265830 |
40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70398270 |
41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.68078355 |
42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64962243 |
43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.64689363 |
44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.64077845 |
45 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.61320337 |
46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60413345 |
47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60056666 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56625539 |
49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53868356 |
50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51584502 |
51 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50423446 |
52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49880915 |
53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47099003 |
54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46582477 |
55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43390452 |
56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43024764 |
57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41418582 |
58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41210650 |
59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40159534 |
60 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39232725 |
61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37573031 |
62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37326191 |
63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36716084 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31786012 |
65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30711775 |
66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30623470 |
67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29533471 |
68 | JUN_21703547_ChIP-Seq_K562_Human | 1.28630624 |
69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27838830 |
70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27345190 |
71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26589590 |
72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25393959 |
73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23569302 |
74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21938822 |
75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19797630 |
76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19761106 |
77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19715122 |
78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18526125 |
79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17184513 |
80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16989220 |
81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16989220 |
82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16418117 |
83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16354876 |
84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15043881 |
85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14937598 |
86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13184294 |
87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12667591 |
88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12499557 |
89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12438836 |
90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11974870 |
91 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11704915 |
92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10552244 |
93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08850896 |
94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08520427 |
95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08233881 |
96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08215145 |
97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08202037 |
98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08202037 |
99 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05597040 |
100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05405550 |
101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05015427 |
102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04933590 |
103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04180206 |
104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03344142 |
105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03298883 |
106 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02879776 |
107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01862175 |
108 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01579359 |
109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01486283 |
110 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01462265 |
111 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00976021 |
112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00873392 |
113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00866992 |
114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00187923 |
115 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.98749225 |
116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98023773 |
117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97757679 |
118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97515329 |
119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97416736 |
120 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97289576 |
121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93745802 |
122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93083791 |
123 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92962141 |
124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92962141 |
125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91135601 |
126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90586982 |
127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90348621 |
128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90348621 |
129 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89332440 |
130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87325648 |
131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86271420 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.66699145 |
2 | MP0001529_abnormal_vocalization | 3.78251452 |
3 | MP0006276_abnormal_autonomic_nervous | 3.63062552 |
4 | MP0004859_abnormal_synaptic_plasticity | 3.40621784 |
5 | MP0009046_muscle_twitch | 3.33820069 |
6 | * MP0003635_abnormal_synaptic_transmissio | 3.32492472 |
7 | MP0001968_abnormal_touch/_nociception | 3.17120505 |
8 | * MP0009745_abnormal_behavioral_response | 3.13099428 |
9 | * MP0002064_seizures | 2.99667035 |
10 | MP0001440_abnormal_grooming_behavior | 2.95370919 |
11 | MP0003122_maternal_imprinting | 2.77743023 |
12 | MP0002736_abnormal_nociception_after | 2.73161143 |
13 | MP0001501_abnormal_sleep_pattern | 2.56102379 |
14 | MP0000569_abnormal_digit_pigmentation | 2.54972153 |
15 | * MP0002572_abnormal_emotion/affect_behav | 2.53891427 |
16 | * MP0002063_abnormal_learning/memory/cond | 2.52999862 |
17 | MP0002272_abnormal_nervous_system | 2.49497011 |
18 | MP0005423_abnormal_somatic_nervous | 2.46777707 |
19 | MP0004142_abnormal_muscle_tone | 2.46681336 |
20 | MP0008877_abnormal_DNA_methylation | 2.39978984 |
21 | MP0001986_abnormal_taste_sensitivity | 2.31364344 |
22 | MP0001905_abnormal_dopamine_level | 2.29461329 |
23 | MP0002734_abnormal_mechanical_nocicepti | 2.23165565 |
24 | MP0004270_analgesia | 2.20873557 |
25 | MP0001486_abnormal_startle_reflex | 2.20563153 |
26 | MP0005386_behavior/neurological_phenoty | 2.13274888 |
27 | MP0004924_abnormal_behavior | 2.13274888 |
28 | MP0002067_abnormal_sensory_capabilities | 2.08875452 |
29 | MP0002837_dystrophic_cardiac_calcinosis | 2.08637719 |
30 | MP0002822_catalepsy | 2.01419816 |
31 | MP0002735_abnormal_chemical_nociception | 1.96636675 |
32 | MP0002733_abnormal_thermal_nociception | 1.93269655 |
33 | MP0001970_abnormal_pain_threshold | 1.92038848 |
34 | MP0005645_abnormal_hypothalamus_physiol | 1.89549403 |
35 | MP0004885_abnormal_endolymph | 1.88660543 |
36 | MP0001984_abnormal_olfaction | 1.88433267 |
37 | MP0004147_increased_porphyrin_level | 1.81124226 |
38 | MP0003195_calcinosis | 1.72568005 |
39 | MP0002557_abnormal_social/conspecific_i | 1.68516403 |
40 | MP0001188_hyperpigmentation | 1.67029674 |
41 | MP0002184_abnormal_innervation | 1.65854238 |
42 | MP0003329_amyloid_beta_deposits | 1.64351588 |
43 | MP0000778_abnormal_nervous_system | 1.62527154 |
44 | MP0000427_abnormal_hair_cycle | 1.49233452 |
45 | MP0005646_abnormal_pituitary_gland | 1.46869484 |
46 | MP0006072_abnormal_retinal_apoptosis | 1.46690888 |
47 | MP0000751_myopathy | 1.46203949 |
48 | MP0005379_endocrine/exocrine_gland_phen | 1.43143066 |
49 | MP0004043_abnormal_pH_regulation | 1.38853737 |
50 | MP0006035_abnormal_mitochondrial_morpho | 1.36642369 |
51 | MP0010386_abnormal_urinary_bladder | 1.36203424 |
52 | MP0004742_abnormal_vestibular_system | 1.34847879 |
53 | MP0009379_abnormal_foot_pigmentation | 1.34193336 |
54 | MP0004133_heterotaxia | 1.34168186 |
55 | MP0002876_abnormal_thyroid_physiology | 1.33997583 |
56 | MP0001485_abnormal_pinna_reflex | 1.33601622 |
57 | MP0001502_abnormal_circadian_rhythm | 1.33543478 |
58 | MP0008872_abnormal_physiological_respon | 1.32612112 |
59 | * MP0002066_abnormal_motor_capabilities/c | 1.26947351 |
60 | MP0005551_abnormal_eye_electrophysiolog | 1.26138405 |
61 | MP0005409_darkened_coat_color | 1.24874311 |
62 | MP0005084_abnormal_gallbladder_morpholo | 1.21438984 |
63 | MP0002882_abnormal_neuron_morphology | 1.17086421 |
64 | MP0002332_abnormal_exercise_endurance | 1.14343336 |
65 | MP0005174_abnormal_tail_pigmentation | 1.13233779 |
66 | MP0003121_genomic_imprinting | 1.11045126 |
67 | MP0008569_lethality_at_weaning | 1.09024129 |
68 | MP0000955_abnormal_spinal_cord | 1.05925048 |
69 | MP0000631_abnormal_neuroendocrine_gland | 1.05744332 |
70 | MP0004145_abnormal_muscle_electrophysio | 1.05528203 |
71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04860388 |
72 | MP0003011_delayed_dark_adaptation | 1.03471703 |
73 | MP0000013_abnormal_adipose_tissue | 1.02654703 |
74 | MP0005535_abnormal_body_temperature | 1.02270300 |
75 | MP0002163_abnormal_gland_morphology | 1.00581063 |
76 | MP0003890_abnormal_embryonic-extraembry | 0.98968290 |
77 | MP0002229_neurodegeneration | 0.96823366 |
78 | MP0003123_paternal_imprinting | 0.96358563 |
79 | MP0002909_abnormal_adrenal_gland | 0.94636337 |
80 | MP0002152_abnormal_brain_morphology | 0.90225673 |
81 | MP0002090_abnormal_vision | 0.90049321 |
82 | MP0004811_abnormal_neuron_physiology | 0.88981002 |
83 | MP0002160_abnormal_reproductive_system | 0.88196571 |
84 | MP0001963_abnormal_hearing_physiology | 0.88173499 |
85 | MP0002069_abnormal_eating/drinking_beha | 0.87883373 |
86 | MP0001919_abnormal_reproductive_system | 0.87688152 |
87 | MP0003633_abnormal_nervous_system | 0.85110308 |
88 | MP0001664_abnormal_digestion | 0.83904339 |
89 | MP0003879_abnormal_hair_cell | 0.83335810 |
90 | MP0002752_abnormal_somatic_nervous | 0.82878350 |
91 | MP0004085_abnormal_heartbeat | 0.82580636 |
92 | MP0005389_reproductive_system_phenotype | 0.82218597 |
93 | MP0002638_abnormal_pupillary_reflex | 0.81045312 |
94 | MP0005394_taste/olfaction_phenotype | 0.79388750 |
95 | MP0005499_abnormal_olfactory_system | 0.79388750 |
96 | MP0000747_muscle_weakness | 0.77990604 |
97 | MP0003690_abnormal_glial_cell | 0.77661139 |
98 | MP0000604_amyloidosis | 0.77429136 |
99 | MP0008874_decreased_physiological_sensi | 0.76760805 |
100 | MP0005671_abnormal_response_to | 0.75904959 |
101 | MP0002751_abnormal_autonomic_nervous | 0.75559554 |
102 | MP0002928_abnormal_bile_duct | 0.75550906 |
103 | MP0003137_abnormal_impulse_conducting | 0.74631307 |
104 | MP0003634_abnormal_glial_cell | 0.74367563 |
105 | MP0003631_nervous_system_phenotype | 0.74011722 |
106 | MP0004858_abnormal_nervous_system | 0.72347401 |
107 | MP0005195_abnormal_posterior_eye | 0.72094768 |
108 | MP0001943_abnormal_respiration | 0.71733930 |
109 | MP0000538_abnormal_urinary_bladder | 0.70948616 |
110 | MP0002234_abnormal_pharynx_morphology | 0.69266100 |
111 | MP0003938_abnormal_ear_development | 0.68550634 |
112 | MP0002277_abnormal_respiratory_mucosa | 0.68195020 |
113 | MP0009780_abnormal_chondrocyte_physiolo | 0.68169077 |
114 | MP0000920_abnormal_myelination | 0.68159874 |
115 | MP0003252_abnormal_bile_duct | 0.67776226 |
116 | MP0000639_abnormal_adrenal_gland | 0.67672136 |
117 | MP0003698_abnormal_male_reproductive | 0.67346360 |
118 | MP0005310_abnormal_salivary_gland | 0.67110671 |
119 | MP0000026_abnormal_inner_ear | 0.66760342 |
120 | MP0002102_abnormal_ear_morphology | 0.66721753 |
121 | MP0003787_abnormal_imprinting | 0.65845896 |
122 | MP0001727_abnormal_embryo_implantation | 0.64780385 |
123 | MP0005623_abnormal_meninges_morphology | 0.64738113 |
124 | MP0004272_abnormal_basement_membrane | 0.64646284 |
125 | MP0005253_abnormal_eye_physiology | 0.63816447 |
126 | MP0004215_abnormal_myocardial_fiber | 0.63276366 |
127 | MP0006292_abnormal_olfactory_placode | 0.63064933 |
128 | MP0004484_altered_response_of | 0.62481395 |
129 | MP0001177_atelectasis | 0.59573507 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.23137663 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 5.08066870 |
3 | Atonic seizures (HP:0010819) | 4.60002860 |
4 | Progressive macrocephaly (HP:0004481) | 4.58553626 |
5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.53370958 |
6 | Focal seizures (HP:0007359) | 4.43831136 |
7 | Mitochondrial inheritance (HP:0001427) | 4.38963746 |
8 | Visual hallucinations (HP:0002367) | 4.33001558 |
9 | Absence seizures (HP:0002121) | 4.08460945 |
10 | Type II lissencephaly (HP:0007260) | 4.04021749 |
11 | Acute encephalopathy (HP:0006846) | 3.97712663 |
12 | Limb dystonia (HP:0002451) | 3.79936362 |
13 | Pancreatic cysts (HP:0001737) | 3.71723674 |
14 | Myokymia (HP:0002411) | 3.70861924 |
15 | Dialeptic seizures (HP:0011146) | 3.70077123 |
16 | Abnormal ciliary motility (HP:0012262) | 3.60634117 |
17 | Febrile seizures (HP:0002373) | 3.56585325 |
18 | Infantile muscular hypotonia (HP:0008947) | 3.56133172 |
19 | Increased CSF lactate (HP:0002490) | 3.52418044 |
20 | Generalized tonic-clonic seizures (HP:0002069) | 3.45465027 |
21 | Epileptic encephalopathy (HP:0200134) | 3.38376280 |
22 | Congenital stationary night blindness (HP:0007642) | 3.36815080 |
23 | Pancreatic fibrosis (HP:0100732) | 3.35493561 |
24 | Polyphagia (HP:0002591) | 3.28080759 |
25 | Increased hepatocellular lipid droplets (HP:0006565) | 3.26316555 |
26 | Hepatocellular necrosis (HP:0001404) | 3.22489360 |
27 | True hermaphroditism (HP:0010459) | 3.14127745 |
28 | Cerebral inclusion bodies (HP:0100314) | 3.09779720 |
29 | Neurofibrillary tangles (HP:0002185) | 3.01428187 |
30 | Gait imbalance (HP:0002141) | 3.00137648 |
31 | Optic disc pallor (HP:0000543) | 2.98111954 |
32 | Cerebellar dysplasia (HP:0007033) | 2.97049476 |
33 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.95366497 |
34 | Progressive cerebellar ataxia (HP:0002073) | 2.92739202 |
35 | Nephronophthisis (HP:0000090) | 2.92384936 |
36 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.90699212 |
37 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.90699212 |
38 | Hyperventilation (HP:0002883) | 2.89937735 |
39 | Progressive inability to walk (HP:0002505) | 2.83566679 |
40 | Broad-based gait (HP:0002136) | 2.81144688 |
41 | Absent/shortened dynein arms (HP:0200106) | 2.80787305 |
42 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.80787305 |
43 | Renal Fanconi syndrome (HP:0001994) | 2.79161651 |
44 | Genetic anticipation (HP:0003743) | 2.78737570 |
45 | Congenital primary aphakia (HP:0007707) | 2.75912084 |
46 | Chronic hepatic failure (HP:0100626) | 2.73871962 |
47 | Medial flaring of the eyebrow (HP:0010747) | 2.73406225 |
48 | Abnormality of the pons (HP:0007361) | 2.72897790 |
49 | Abnormal hair whorl (HP:0010721) | 2.72437791 |
50 | Abnormality of the renal cortex (HP:0011035) | 2.69656523 |
51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.66887051 |
52 | Attenuation of retinal blood vessels (HP:0007843) | 2.62778451 |
53 | Abolished electroretinogram (ERG) (HP:0000550) | 2.62722889 |
54 | Amblyopia (HP:0000646) | 2.60173046 |
55 | Hypothermia (HP:0002045) | 2.59816188 |
56 | Pendular nystagmus (HP:0012043) | 2.59410369 |
57 | Anxiety (HP:0000739) | 2.59259441 |
58 | Abnormal eating behavior (HP:0100738) | 2.58773760 |
59 | Abnormality of the renal medulla (HP:0100957) | 2.58141316 |
60 | Cerebral edema (HP:0002181) | 2.58140212 |
61 | Absent speech (HP:0001344) | 2.50160415 |
62 | Abnormal pupillary function (HP:0007686) | 2.49682227 |
63 | Hyperthyroidism (HP:0000836) | 2.48060572 |
64 | Leukodystrophy (HP:0002415) | 2.46931580 |
65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.46622529 |
66 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.45653445 |
67 | Esotropia (HP:0000565) | 2.44807783 |
68 | Protruding tongue (HP:0010808) | 2.43746451 |
69 | Retinal dysplasia (HP:0007973) | 2.43199202 |
70 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41324062 |
71 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41324062 |
72 | Genital tract atresia (HP:0001827) | 2.41068476 |
73 | Vaginal atresia (HP:0000148) | 2.39244612 |
74 | Hypoplasia of the pons (HP:0012110) | 2.38457587 |
75 | Pheochromocytoma (HP:0002666) | 2.38203886 |
76 | Failure to thrive in infancy (HP:0001531) | 2.36428675 |
77 | Brushfield spots (HP:0001088) | 2.36405376 |
78 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.33584570 |
79 | Cerebral hemorrhage (HP:0001342) | 2.32532964 |
80 | Psychosis (HP:0000709) | 2.30466924 |
81 | Neuroendocrine neoplasm (HP:0100634) | 2.30454356 |
82 | Abnormality of midbrain morphology (HP:0002418) | 2.29390242 |
83 | Molar tooth sign on MRI (HP:0002419) | 2.29390242 |
84 | Rhinitis (HP:0012384) | 2.26721262 |
85 | Respiratory failure (HP:0002878) | 2.26263964 |
86 | Exercise intolerance (HP:0003546) | 2.26141459 |
87 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24916548 |
88 | Rimmed vacuoles (HP:0003805) | 2.23944516 |
89 | Drooling (HP:0002307) | 2.23802747 |
90 | Excessive salivation (HP:0003781) | 2.23802747 |
91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21344372 |
92 | Truncal ataxia (HP:0002078) | 2.21332717 |
93 | Hemiparesis (HP:0001269) | 2.20865148 |
94 | Agitation (HP:0000713) | 2.18779214 |
95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.16840454 |
96 | Pachygyria (HP:0001302) | 2.16432180 |
97 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15687036 |
98 | Abnormality of alanine metabolism (HP:0010916) | 2.15687036 |
99 | Hyperalaninemia (HP:0003348) | 2.15687036 |
100 | CNS hypomyelination (HP:0003429) | 2.15518890 |
101 | X-linked dominant inheritance (HP:0001423) | 2.15031110 |
102 | Tubular atrophy (HP:0000092) | 2.14394699 |
103 | Decreased central vision (HP:0007663) | 2.14203190 |
104 | Abnormality of the corticospinal tract (HP:0002492) | 2.13633200 |
105 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.12963210 |
106 | Thyroid-stimulating hormone excess (HP:0002925) | 2.12559253 |
107 | Hypoventilation (HP:0002791) | 2.11279266 |
108 | Dysmetria (HP:0001310) | 2.11274624 |
109 | Hepatic necrosis (HP:0002605) | 2.10832931 |
110 | Cystic liver disease (HP:0006706) | 2.10594842 |
111 | Abnormal drinking behavior (HP:0030082) | 2.10217007 |
112 | Polydipsia (HP:0001959) | 2.10217007 |
113 | Hypsarrhythmia (HP:0002521) | 2.08432114 |
114 | Narrow nasal bridge (HP:0000446) | 2.06949259 |
115 | Delusions (HP:0000746) | 2.05669669 |
116 | Widely spaced teeth (HP:0000687) | 2.05571636 |
117 | Inability to walk (HP:0002540) | 2.05309045 |
118 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04795582 |
119 | Supranuclear gaze palsy (HP:0000605) | 2.04174350 |
120 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03616301 |
121 | Fair hair (HP:0002286) | 2.03195506 |
122 | Generalized myoclonic seizures (HP:0002123) | 2.02426119 |
123 | Large for gestational age (HP:0001520) | 2.02210820 |
124 | Lissencephaly (HP:0001339) | 2.01080384 |
125 | Poor suck (HP:0002033) | 2.00564704 |
126 | Delayed gross motor development (HP:0002194) | 1.99754093 |
127 | Lactic acidosis (HP:0003128) | 1.98074628 |
128 | Insidious onset (HP:0003587) | 1.96687221 |
129 | Termporal pattern (HP:0011008) | 1.96687221 |
130 | Specific learning disability (HP:0001328) | 1.95991326 |
131 | Epileptiform EEG discharges (HP:0011182) | 1.94134180 |
132 | Oligomenorrhea (HP:0000876) | 1.93814835 |
133 | Severe muscular hypotonia (HP:0006829) | 1.92981594 |
134 | Renal cortical cysts (HP:0000803) | 1.91139851 |
135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90196144 |
136 | Sensory axonal neuropathy (HP:0003390) | 1.90100647 |
137 | Stomach cancer (HP:0012126) | 1.89986827 |
138 | Dysdiadochokinesis (HP:0002075) | 1.89197957 |
139 | Abnormality of the labia minora (HP:0012880) | 1.88234728 |
140 | Keratoconus (HP:0000563) | 1.87592975 |
141 | Increased corneal curvature (HP:0100692) | 1.87592975 |
142 | Gaze-evoked nystagmus (HP:0000640) | 1.85098344 |
143 | Postural tremor (HP:0002174) | 1.84598789 |
144 | Abnormality of renal resorption (HP:0011038) | 1.84264838 |
145 | Status epilepticus (HP:0002133) | 1.82579033 |
146 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.82475541 |
147 | Abnormality of macular pigmentation (HP:0008002) | 1.80896461 |
148 | Decreased circulating renin level (HP:0003351) | 1.79109031 |
149 | Intellectual disability, severe (HP:0010864) | 1.78467284 |
150 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76240442 |
151 | Action tremor (HP:0002345) | 1.74279161 |
152 | Chorioretinal atrophy (HP:0000533) | 1.73365372 |
153 | Congenital hepatic fibrosis (HP:0002612) | 1.72698814 |
154 | Polyuria (HP:0000103) | 1.71369867 |
155 | Generalized hypopigmentation of hair (HP:0011358) | 1.71312290 |
156 | Sclerocornea (HP:0000647) | 1.71183083 |
157 | Clumsiness (HP:0002312) | 1.70929252 |
158 | Oligodactyly (hands) (HP:0001180) | 1.69223702 |
159 | Furrowed tongue (HP:0000221) | 1.68146181 |
160 | Poor coordination (HP:0002370) | 1.67656723 |
161 | Optic nerve hypoplasia (HP:0000609) | 1.67512135 |
162 | Progressive microcephaly (HP:0000253) | 1.67015935 |
163 | Patellar aplasia (HP:0006443) | 1.65746198 |
164 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.65501648 |
165 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65094910 |
166 | Spastic tetraplegia (HP:0002510) | 1.63640124 |
167 | Hemiplegia (HP:0002301) | 1.62381888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 4.66809599 |
2 | PNCK | 4.49901324 |
3 | MAP3K12 | 4.41700473 |
4 | NTRK3 | 3.75469311 |
5 | CASK | 3.08547654 |
6 | MAP3K9 | 2.82067360 |
7 | MAP3K4 | 2.74526879 |
8 | ARAF | 2.60515761 |
9 | EPHA4 | 2.53526215 |
10 | TNIK | 2.35859607 |
11 | MAP2K7 | 2.34569579 |
12 | PINK1 | 2.25053584 |
13 | MAP2K4 | 2.24833494 |
14 | MAP4K2 | 2.24129361 |
15 | ZAK | 2.20723954 |
16 | MINK1 | 2.11996608 |
17 | NME1 | 2.06706767 |
18 | GRK1 | 2.03858170 |
19 | RIPK4 | 1.96718765 |
20 | NUAK1 | 1.96638652 |
21 | NTRK2 | 1.92851877 |
22 | NTRK1 | 1.90826502 |
23 | MARK1 | 1.86958989 |
24 | GRK7 | 1.86869310 |
25 | FES | 1.84734094 |
26 | TLK1 | 1.83056647 |
27 | ACVR1B | 1.76847699 |
28 | GRK5 | 1.70094520 |
29 | ADRBK2 | 1.59684604 |
30 | MAPKAPK5 | 1.48750676 |
31 | MAP3K13 | 1.46659087 |
32 | PLK2 | 1.43197672 |
33 | TXK | 1.42505346 |
34 | TAOK3 | 1.39642745 |
35 | INSRR | 1.34787703 |
36 | STK39 | 1.33120159 |
37 | CAMK2A | 1.30596133 |
38 | OXSR1 | 1.29607764 |
39 | CAMK2B | 1.23234014 |
40 | FGR | 1.22385944 |
41 | BCR | 1.19864542 |
42 | SIK2 | 1.17662791 |
43 | MAPK13 | 1.15444352 |
44 | KSR2 | 1.12238218 |
45 | CDK5 | 1.09267126 |
46 | BMPR2 | 1.06640554 |
47 | TRIM28 | 1.06398873 |
48 | CAMK2D | 1.04996973 |
49 | TNK2 | 1.02669771 |
50 | EPHA3 | 1.02007333 |
51 | MYLK | 0.99364670 |
52 | DYRK2 | 0.98830095 |
53 | PRKCG | 0.97764160 |
54 | CSNK1G2 | 0.97588392 |
55 | CSNK1G3 | 0.94964498 |
56 | UHMK1 | 0.93931769 |
57 | LATS2 | 0.93478869 |
58 | ADRBK1 | 0.91837800 |
59 | MKNK2 | 0.91557050 |
60 | FER | 0.91327570 |
61 | STK38L | 0.90991972 |
62 | KSR1 | 0.90236441 |
63 | CDK19 | 0.90160070 |
64 | CAMK1G | 0.87346084 |
65 | MST4 | 0.86863692 |
66 | PAK6 | 0.85845645 |
67 | PRKCH | 0.85501862 |
68 | CAMKK2 | 0.83617413 |
69 | FGFR2 | 0.82482604 |
70 | PRKCE | 0.81575055 |
71 | GRK6 | 0.81208334 |
72 | PAK3 | 0.81139153 |
73 | PIK3CA | 0.80701372 |
74 | BMPR1B | 0.78308797 |
75 | CAMK2G | 0.77019942 |
76 | PRKD3 | 0.76431384 |
77 | MAP2K6 | 0.76313812 |
78 | DAPK1 | 0.75901015 |
79 | WNK4 | 0.75266698 |
80 | MAPK15 | 0.74567605 |
81 | SGK2 | 0.74266688 |
82 | CDK14 | 0.72945078 |
83 | DAPK2 | 0.69059338 |
84 | PTK2B | 0.68938683 |
85 | MOS | 0.68652391 |
86 | BRAF | 0.68187046 |
87 | TSSK6 | 0.68067297 |
88 | SGK494 | 0.66990316 |
89 | SGK223 | 0.66990316 |
90 | RAF1 | 0.65821720 |
91 | MAP3K6 | 0.65339933 |
92 | ROCK2 | 0.64129281 |
93 | ERBB3 | 0.63554989 |
94 | AKT3 | 0.62419139 |
95 | CDK18 | 0.62229536 |
96 | CCNB1 | 0.62056672 |
97 | CAMK1D | 0.61966559 |
98 | CAMK4 | 0.61176582 |
99 | MUSK | 0.60483016 |
100 | CDK15 | 0.59961593 |
101 | CSNK1G1 | 0.55231535 |
102 | PRKACA | 0.53066589 |
103 | PKN1 | 0.52650066 |
104 | PLK3 | 0.52324697 |
105 | PRKCI | 0.51293892 |
106 | WNK3 | 0.50542089 |
107 | CDK11A | 0.49141975 |
108 | DYRK1A | 0.48705104 |
109 | STK11 | 0.48291769 |
110 | MARK3 | 0.48024929 |
111 | WNK1 | 0.47576898 |
112 | CSNK1E | 0.45605097 |
113 | CAMK1 | 0.45521322 |
114 | PRKG1 | 0.45297711 |
115 | PHKG1 | 0.45146490 |
116 | PHKG2 | 0.45146490 |
117 | CSNK1A1 | 0.44218714 |
118 | CSNK1D | 0.43928694 |
119 | YES1 | 0.43190073 |
120 | RPS6KA5 | 0.42931476 |
121 | VRK1 | 0.42229063 |
122 | MAP2K1 | 0.41173025 |
123 | CSNK1A1L | 0.40618851 |
124 | TGFBR1 | 0.39895475 |
125 | SGK1 | 0.39818198 |
126 | CAMKK1 | 0.39041213 |
127 | TAF1 | 0.38124159 |
128 | FYN | 0.37485969 |
129 | MAP3K1 | 0.36116646 |
130 | TEC | 0.35724771 |
131 | SIK3 | 0.35321382 |
132 | PRKCA | 0.35015500 |
133 | STK38 | 0.34424418 |
134 | PDK1 | 0.33427201 |
135 | PRKCB | 0.32682497 |
136 | RPS6KA3 | 0.31754152 |
137 | PRKCQ | 0.29764439 |
138 | PRKCZ | 0.29161704 |
139 | TYRO3 | 0.28413177 |
140 | RET | 0.26735565 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.89312103 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.27853507 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.92548731 |
4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.33888892 |
5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.90890907 |
6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.77844463 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72549601 |
8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.70612272 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57427052 |
10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.47657155 |
11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.28025827 |
12 | Morphine addiction_Homo sapiens_hsa05032 | 2.19112506 |
13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.15664027 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.13994710 |
15 | Taste transduction_Homo sapiens_hsa04742 | 2.10413226 |
16 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06804589 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.01479090 |
18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94222462 |
19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93717253 |
20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91941658 |
21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86909319 |
22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.85569983 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.83632987 |
24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80949130 |
25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.79623253 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76838971 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74929353 |
28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.73912080 |
29 | Long-term depression_Homo sapiens_hsa04730 | 1.69882587 |
30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.69506821 |
31 | Salivary secretion_Homo sapiens_hsa04970 | 1.59115128 |
32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46864048 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39623582 |
34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37963133 |
35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36095794 |
36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35296483 |
37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34603357 |
38 | Insulin secretion_Homo sapiens_hsa04911 | 1.33985344 |
39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.25325417 |
40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21978123 |
41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21483271 |
42 | Phototransduction_Homo sapiens_hsa04744 | 1.18003836 |
43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15897688 |
44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15461277 |
45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14973444 |
46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12784301 |
47 | RNA polymerase_Homo sapiens_hsa03020 | 1.11903865 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11014020 |
49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06066348 |
50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05608211 |
51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05466165 |
52 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04677248 |
53 | Homologous recombination_Homo sapiens_hsa03440 | 1.04496606 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99015417 |
55 | Gap junction_Homo sapiens_hsa04540 | 0.99004327 |
56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97864909 |
57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91624465 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90634258 |
59 | Protein export_Homo sapiens_hsa03060 | 0.88860592 |
60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85894469 |
61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85680020 |
62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83904949 |
63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81908264 |
64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81674371 |
65 | Peroxisome_Homo sapiens_hsa04146 | 0.80939039 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77985893 |
67 | Melanogenesis_Homo sapiens_hsa04916 | 0.77059531 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.76695012 |
69 | Axon guidance_Homo sapiens_hsa04360 | 0.75354090 |
70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74554851 |
71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71259918 |
72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70228330 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.68147546 |
74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66549488 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65504228 |
76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64493991 |
77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64412950 |
78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63617652 |
79 | RNA degradation_Homo sapiens_hsa03018 | 0.62300566 |
80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61875542 |
81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60450765 |
82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58567369 |
83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57244813 |
84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56295512 |
85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55898927 |
86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55549992 |
87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54428798 |
88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53221027 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.50779410 |
90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49904902 |
91 | Phagosome_Homo sapiens_hsa04145 | 0.46980682 |
92 | Purine metabolism_Homo sapiens_hsa00230 | 0.46965518 |
93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46621647 |
94 | Alcoholism_Homo sapiens_hsa05034 | 0.46120596 |
95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44820348 |
96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44147731 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44046740 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43185831 |
99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42509420 |
100 | Asthma_Homo sapiens_hsa05310 | 0.42471411 |
101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42380085 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40237610 |
103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40003839 |
104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39847638 |
105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38596808 |
106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36947712 |
107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36489407 |
108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36340594 |
109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36257355 |
110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36174780 |
111 | Ribosome_Homo sapiens_hsa03010 | 0.36032320 |
112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34464432 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34355219 |
114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33960645 |
115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32862437 |
116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31694751 |
117 | Glioma_Homo sapiens_hsa05214 | 0.31535949 |
118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30963267 |
119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30674116 |
120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30157912 |
121 | Proteasome_Homo sapiens_hsa03050 | 0.29750061 |
122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29351494 |
123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25700766 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25041478 |
125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24256120 |
126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23807425 |
127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23131687 |
128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22696246 |
129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21673658 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20311269 |
131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19757920 |
132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19644161 |
133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.18660352 |
134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18528213 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18514532 |
136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.17775098 |
137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17752120 |
138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15245533 |
139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13195356 |
140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.10210889 |
141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.09575732 |
142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.09515935 |